301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1830507963420246016 |
---|---|
author | Christina Hartl Tillmann Michels Ronny Milde Vanessa Klein Philipp Beckhove Hannes Loferer Stefan Bissinger |
author_facet | Christina Hartl Tillmann Michels Ronny Milde Vanessa Klein Philipp Beckhove Hannes Loferer Stefan Bissinger |
author_sort | Christina Hartl |
collection | DOAJ |
first_indexed | 2024-12-22T01:13:15Z |
format | Article |
id | doaj.art-423953da805c440f99710906966560cd |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-12-22T01:13:15Z |
publishDate | 2021-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-423953da805c440f99710906966560cd2022-12-21T18:43:55ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.301301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibitionChristina Hartl0Tillmann Michels1Ronny Milde2Vanessa Klein3Philipp Beckhove4Hannes Loferer5Stefan Bissinger61Dana Farber Cancer Institute, Boston, MA, USA1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany2RCI Center for Interventional Immunology, Regensburg, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany1iOmx Therapeutics AG, Martinsried/Munich, Germany |
spellingShingle | Christina Hartl Tillmann Michels Ronny Milde Vanessa Klein Philipp Beckhove Hannes Loferer Stefan Bissinger 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition Journal for ImmunoTherapy of Cancer |
title | 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
title_full | 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
title_fullStr | 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
title_full_unstemmed | 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
title_short | 301 OMX-0407, a highly potent SIK3 inhibitor, sensitizes tumor cells to apoptosis and eradicates tumors in combination with PD-1 inhibition |
title_sort | 301 omx 0407 a highly potent sik3 inhibitor sensitizes tumor cells to apoptosis and eradicates tumors in combination with pd 1 inhibition |
work_keys_str_mv | AT christinahartl 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT tillmannmichels 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT ronnymilde 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT vanessaklein 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT philippbeckhove 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT hannesloferer 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition AT stefanbissinger 301omx0407ahighlypotentsik3inhibitorsensitizestumorcellstoapoptosisanderadicatestumorsincombinationwithpd1inhibition |